Before: Confusion
Many residents face mixed signals about policy and treatment options; our arriving documentation reduces that friction.
Basalt Lantern collects, clarifies, and presents evidence about ibogaine policy and practical access in Colorado. Our work emphasizes transparency in sourcing, clear editorial boundaries, and measurable improvements in public understanding.
Structured summaries of legal and research sources.
Accessible links to clinic, cost, and treatment overviews.
Prioritizes risk context and authoritative guidance.
Many residents face mixed signals about policy and treatment options; our arriving documentation reduces that friction.
Readers report better-informed conversations with clinicians and policymakers after using our resources.
We track corrections and updates to maintain a reliable baseline of facts.
Wide Anchor 18 exists to provide an independent reference about Ibogaine In Colorado: Where The Law Stands; our mission is to clarify the difference between decriminalization, regulated access, federal restrictions, and medical approval for readers in Colorado. To see the broader site context and navigational hub, our homepage is available at the site’s main overview, which links into topical pages and resources.
We synthesize primary materials (statutes, rule texts), peer-reviewed literature, and documented program descriptions. Where helpful, we link to treatment provider and cost overviews such as the operational summaries found at ibogaine treatments in Mexico and public summaries of program fees like those at ibogaine treatment cost guides.
To support claims about clinical research and therapeutic interest, we reference authoritative resources: for general substance and policy background we consult encyclopedic summaries such as the comprehensive entry on ibogaine at Wikipedia’s ibogaine article, and for regulatory frameworks we reference high-level guidance and public health pages such as those hosted by state and federal agencies like the U.S. Department of Health and Human Services (hhs.gov). These sources are used to corroborate claims, not to replace primary statutory texts.
Content is organized by practical strands: policy analysis, clinic & access summaries, safety considerations, and research pathways. For readers exploring treatment-adjacent resources, our editorial pages link to content about specialized programs such as veteran-focused resources like ibogaine care options for veterans and condition-specific discussions like treatment research for Parkinson’s.
Our intended audience includes Colorado residents, families, clinicians seeking context, researchers, and policymakers. Where appropriate we surface practical listings and directories — for example, comparative program descriptions like those on ibogaine practitioner directories and community marketplaces such as ibogaine exchange listings.
Our work is governed by concise, demonstrable standards intended to keep material useful, attributable, and safe.
Every factual claim links to its provenance wherever possible: statutes, regulatory notices, court opinions, peer-reviewed studies, or official program descriptions. When primary law is ambiguous we note the uncertainty rather than assert a definitive position.
We maintain a small corrections log attached to evolving pages, and updates are dated so readers can track when guidance changed. For a broad view of registries and program overviews we occasionally reference external specialist sites in context to help readers compare options.
Basalt Lantern is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. This disclosure appears on every page to make our role plain.